Max Taubert
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
- Pharmacology 19
- Antibiotics Pharmacokinetics and Efficacy 17
- Pharmacogenetics and Drug Metabolism 7
-
- Pharmaceutical studies and practices 3
- Pharmacological Effects and Toxicity Studies 3
- Co-authors
- Uwe Fuhr (32 shared papers)Michael Zöller (7 shared papers)Michael Vogeser (4 shared papers)Christina Scharf (4 shared papers)Sebastian Frechen (5 shared papers)Johannes Zander (5 shared papers)Lorenz Frey (2 shared papers)Martin H. J. Wiesen (4 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (5 papers)European Journal of Clinical Pharmacology (5 papers)Journal of Antimicrobial Chemotherapy (3 papers)Scientific Reports (3 papers)Clinical Pharmacology & Therapeutics (3 papers)
- Partner nations
- GermanyChinaSaudi Arabia
In The Last Decade
Max Taubert
38 papers receiving 473 citations
Peers
Comparison fields: 5 of 88
- Applied Microbiology and Biotechnology 45
- Molecular Medicine 71
- Pharmacology 207
- Internal Medicine 31
- Pharmacology 66
Countries citing papers authored by Max Taubert
This map shows the geographic impact of Max Taubert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Taubert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Taubert more than expected).
Fields of papers citing papers by Max Taubert
This network shows the impact of papers produced by Max Taubert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Taubert. The network helps show where Max Taubert may publish in the future.
Co-authors
The 25 scholars most cited alongside Max Taubert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 62 | |
| 2 | 2020 | 46 | |
| 3 | 2019 | 46 | |
| 4 | 2016 | 46 | |
| 5 | 2019 | 28 | |
| 6 | 2017 | 26 | |
| 7 | 2021 | 23 | |
| 8 | 2021 | 20 | |
| 9 | 2018 | 17 | |
| 10 | 2018 | 17 | |
| 11 | 2020 | 15 | |
| 12 | 2020 | 15 | |
| 13 | 2018 | 13 | |
| 14 | 2020 | 11 | |
| 15 | 2020 | 9 | |
| 16 | 2019 | 9 | |
| 17 | 2018 | 8 | |
| 18 | 2023 | 8 | |
| 19 | 2023 | 6 | |
| 20 | 2023 | 5 |
About Max Taubert
Max Taubert is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health, Pharmacology, Oncology and Infectious Diseases, having authored 42 papers that have together received 478 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (17 papers), Pharmacogenetics and Drug Metabolism (7 papers), Antibiotic Resistance in Bacteria (5 papers), Drug Transport and Resistance Mechanisms (5 papers), Pharmaceutical studies and practices (3 papers), Pneumonia and Respiratory Infections (3 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (45 citations), Molecular Medicine (71 citations), Pharmacology (207 citations), Internal Medicine (31 citations) and Pharmacology (66 citations). Max Taubert has collaborated with scholars based in Germany, China and Saudi Arabia. Frequent co-authors include Uwe Fuhr, Michael Zöller, Michael Vogeser, Christina Scharf, Sebastian Frechen, Johannes Zander, Lorenz Frey, Martin H. J. Wiesen, Uwe Liebchen and Xia Li. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, European Journal of Clinical Pharmacology, Journal of Antimicrobial Chemotherapy, Scientific Reports and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.